Cytotoxic CD8+ T cells are the main effector cells in anti‐tumor immunity and constitute the cornerstone of cancer immunotherapy.[48] Given that DMR enhances the potential of cancer immunotherapy, we next investigated whether CD8+ T cells are involved in the regulation of tumor progression by DMR. The gene discussed is CD8A; the disease is neoplasm.